Tubeless insulin pumps are small, computerized devices that mimic the way the human pancreas works by delivering small doses of short-acting insulin continuously. Moreover, tubeless insulin pumps are tiny, unobtrusive, and lightweight and are also referred to as insulin patch pumps. The products are discrete, cost-effective, easily adhere to the human body, and easy to use. Patients having type 1 diabetes prefer tubeless insulin pumps. It can be worn and effectively handled under clothing.
MARKET DYNAMICS
The tubeless insulin pump market is owing to drive due to the advancement of new technology. Moreover, increasing government initiatives and rising awareness about diabetes will positively influence market growth over the upcoming years. However, limited reimbursement for tubeless insulin pump and significantly increasing cost of insulin delivery systems may hamper the market growth in forthcoming years..
MARKET SCOPE
The "Tubeless Insulin Pumps Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of in tubeless insulin pumps market with detailed market segmentation by component and distribution channel. The tubeless insulin pumps market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading tubeless insulin pumps market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The tubeless insulin pumps market is segmented on the basis of component and distribution channel. Based on component the market is segmented as pod/patch and remote. On the basis of distribution channel, the market is categorized as hospitals, pharmacies and e-commerce.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in tubeless insulin pumps market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The tubeless insulin pumps market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting tubeless insulin pumps market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the tubeless insulin pumps market in these regions.
MARKET PLAYERS
The report covers key developments in the in tubeless insulin pumps market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in tubeless insulin pumps market are anticipated to have lucrative growth opportunities in the future with the rising demand for in tubeless insulin pumps market in the global market. Below mentioned is the list of few companies engaged in the tubeless insulin pumps market.
The report also includes the profiles of key in tubeless insulin pumps market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Diabetes Care
- Cellnovo Group SA
- CeQur SA
- Debiotech
- Insulet Corporation
- Johnson & Johnson
- Medtrum Technologies Inc
- Roche Holding AG
- Spring Health Solution Ltd.
- Valeritas
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.